Method to determine treatment of acute heart failure

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9638701
SERIAL NO

14750609

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method is described for treating a subject having acute heart failure (AHF) by measuring PERLECAN levels in the subject. The PERLECAN level in the subject is used to determine risk of mortality within one year for the subject. Treatment is selected on the basis of the outcome of the assay.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MYCARTIS NV9052 ZWIJNAARDE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kas, Koen Schilde, BE 34 151
Moerman, Piet Deurle, BE 26 2433
Vanpoucke, Griet Ingooigem, BE 10 89

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 2, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 2, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00